The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global safety needles market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Safety needles are used to deliver drugs, collect fluids from the body, and prevent the spread of needlestick injuries or infections associated with healthcare provision. They protect healthcare workers and patients from bloodborne pathogens and hazardous drug exposure. Some of the widely available safety needles are biopsy, Huber, cannula, pen, suture, prefilled, hypodermic, fine aspirating, intravenous (IV) catheter, blood collection, arteriovenous (AV) fistula, and spinal anesthesia and epidural. Nowadays, automated pen needles with built-in safety features are being introduced to provide various benefits in insulin injection.
Injections are considered a main source of infection in transmitting bloodborne diseases, such as Hepatitis B, D, and C and Human Immunodeficiency Virus (HIV). As a result, health agencies of several countries are implementing laws for safe injection practices, which represents one of the major factors impelling the growth of the market. Safety needles help reduce the incidences of iatrogenic infection and save costs. In addition, they are used to prevent the transmission risk of bloodborne viruses and protect patients from needlestick injuries while administering coronavirus disease (COVID-19) vaccines. Apart from this, due to the growing prevalence of chronic diseases and awareness about the risk associated with filled syringes, there is a rise in the adoption of prefilled syringes across the globe, which, in turn, is driving the market. Moreover, several health firms are introducing needle-based safety devices that can be attached to a conventional or prefilled syringe. Furthermore, initiatives undertaken by governing agencies of numerous countries for needle disposal are projected to aid the market growth. For instance, a program was launched in the City of Bloomington (United States) to install sharps containers in public parks and address the increasing number of used syringes.
IMARC Group provides an analysis of the key trends in each sub-segment of the global safety needles market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on design, product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Johnson & Johnson, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Smiths Group plc, Terumo Corporation and Vygon.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Johnson & Johnson, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Smiths Group plc, Terumo Corporation and Vygon.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at